Brief: Mayne Pharma Gives Update On Scheme With Cosette Pharmaceuticals
May 21 (Reuters) - Mayne Pharma Group Ltd MYX.AX: UPDATE ON SCHEME WITH COSETTE REJECTS COSETTE'S MATERIAL ADVERSE CHANGE CLAIM COSETTE ASSERTS MATERIAL ADVERSE CHANGE IN MAYNE PHARMA DEAL WILL CONTINUE TO PROVIDE COSETTE WITH INFORMATION UNDER TERMS OF SID AS REQUIRED Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)